
News|Articles|August 1, 2003
Statin therapy decreases risk of macrovascular disease and death in diabetic patients
Individuals with diabetes are more prone to cardiovascular morbidity and mortality. However, because their low-density lipoprotein (LDL) cholesterol is similar to that of the general population, they do not usually receive statin or other cholesterol-lowering therapy.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Brandon Kessler on pharmacy pricing under CAA 2026 | PBMI 2026
4
Brandon Kessler on advice to employers about meeting their fiduciary responsibility | PBMI 2026
5























